• Profile
Close

Prognostic role of neutrophil-to-lymphocyte ratio in unresectable hepatocellular cancer patients treated with trans-arterial chemoembolization

Translational Cancer Research Sep 07, 2018

Xu W, et al. - In survival outcomes of hepatocellular carcinoma (HCC) patients receiving trans-arterial chemoembolization (TACE) by systematical review of the present literature, authors ascertained the prognostic value of neutrophil-to-lymphocyte ratio (NLR). In patients with unresectable HCC undergoing TACE, NLR harbored its important value in prognostic prediction as a convenient, inexpensive and easily available inflammatory biomarker. Findings did not suggest an association of the NLR change trend between pre-and post-TACE with either tumor response to TACE or hepatic progression, whereas its prognostic role with overall survival (OS) was also controversial.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay